Conference
P607 Higher adalimumab serum levels do not increase the risk of adverse events in patients with inflammatory bowel disease
Authors
Narula N; Lauzon B; Marshall J
Volume
13
Pagination
pp. s420-s420
Publisher
Oxford University Press (OUP)
Publication Date
January 25, 2019
DOI
10.1093/ecco-jcc/jjy222.731
Conference proceedings
Journal of Crohn's and Colitis
Issue
Supplement_1
ISSN
1197-4982